new psychoactive substance
(12) Covered synthetic drugs and new psychoactive substances.— (A) Covered synthetic drugs .— Information that contains an assessment of the countries significantly involved in the manufacture, production, transshipment, or trafficking of covered synthetic drugs, to include the following: (i) The scale of legal domestic production and any available information on the number of manufacturers and producers of such drugs in such countries. (ii) Information on any law enforcement assessments of the scale of illegal production of such drugs, including a description of the capacity of illegal laboratories to produce such drugs. (iii) The types of inputs used and a description of the primary methods of synthesis employed by illegal producers of such drugs. (iv) An assessment of the policies of such countries to regulate licit manufacture and interdict illicit manufacture, diversion, distribution, shipment, and trafficking of such drugs and an assessment of the effectiveness of the policies’ implementation. (B) New psychoactive substances .— Information on, to the extent practicable, any policies of responding to new psychoactive substances, to include the following: (i) Which governments have articulated policies on scheduling of such substances. (ii) Any data on impacts of such policies and other responses to such substances. (iii) An assessment of any policies the United States could adopt to improve its response to new psychoactive substances. (C) Definitions .— In this paragraph, the terms “covered synthetic drug” and “new psychoactive substance” have the meaning given those terms in section 5558 of the FENTANYL Results Act.